Педиатрия
Prevenar 13
PDA
Ru
Uz
En
Measles, mumps and rubella vaccine
PDA Vaccine (MMR Vaccine)
Composition and form of issue:
PDA Vaccine
— Live attenuated measles, mumps and rubella viruses
Lyophilised powder form
for suspension for subcutaneous or intramuscular administration
Manufacturer:
GlaxoSmithKline Biologicals, Belgium
Indications:
Prevention of measles, mumps and rubella in children and adults
Age guidelines and vaccination schedule:
Children: The first dose is given between 12 and 15 months of age, the second dose between 4 and 6 years of age.
Adolescents and adults: Vaccination is recommended for those who were
Introduction method:
The vaccine is administered in a single dose of 0.5 ml subcutaneously or intramuscularly, preferably in the deltoid muscle of the upper arm.
Contraindications:
Allergic reactions to a previous dose of PDA vaccine or to vaccine components (egg gelatin, neomycin).
Severe immunodeficiency conditions (such as HIV/AIDS).
Pregnancy (vaccination should be delayed until after delivery).
Current severe infectious diseases or chronic diseases during exacerbation. Vaccination is carried out after recovery or during remission.
Be sure to get checked out by a pediatrician before getting vaccinated!
Your child's health is our priority
Our clinic provides comprehensive medical care for newborns, infants and children.
Make an appointment
Sign up for vaccination
Sign up